Exact Mass: 524.2522
Exact Mass Matches: 524.2522
Found 173 metabolites which its exact mass value is equals to given mass value 524.2522
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Fedratinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EJ - Janus-associated kinase (jak) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C125450 - JAK2 Inhibitor
Ser Gln Tyr Lys
Valtrate hydrine B4
Glu Ile Thr Tyr
Glu Ile Tyr Thr
Glu Leu Thr Tyr
Glu Leu Tyr Thr
Glu Thr Ile Tyr
Glu Thr Leu Tyr
Glu Thr Tyr Ile
Glu Thr Tyr Leu
Glu Tyr Ile Thr
Glu Tyr Leu Thr
Glu Tyr Thr Ile
Glu Tyr Thr Leu
Ile Glu Thr Tyr
Ile Glu Tyr Thr
Ile Thr Glu Tyr
Ile Thr Tyr Glu
Ile Tyr Glu Thr
Ile Tyr Thr Glu
Lys Asn Thr Tyr
Lys Asn Tyr Thr
Lys Gln Ser Tyr
Lys Gln Tyr Ser
Lys Ser Gln Tyr
Lys Ser Tyr Gln
Lys Thr Asn Tyr
Lys Thr Tyr Asn
Lys Tyr Asn Thr
Lys Tyr Gln Ser
Lys Tyr Ser Gln
Lys Tyr Thr Asn
Leu Glu Thr Tyr
Leu Glu Tyr Thr
Leu Thr Glu Tyr
Leu Thr Tyr Glu
Leu Tyr Glu Thr
Leu Tyr Thr Glu
Asn Lys Thr Tyr
Asn Lys Tyr Thr
Asn Thr Lys Tyr
Asn Thr Tyr Lys
Asn Tyr Lys Thr
Asn Tyr Thr Lys
Gln Lys Ser Tyr
Gln Lys Tyr Ser
Gln Ser Lys Tyr
Gln Ser Tyr Lys
Gln Tyr Lys Ser
Gln Tyr Ser Lys
Ser Lys Gln Tyr
Ser Lys Tyr Gln
Ser Gln Lys Tyr
Ser Tyr Lys Gln
Ser Tyr Gln Lys
Thr Glu Ile Tyr
Thr Glu Leu Tyr
Thr Glu Tyr Ile
Thr Glu Tyr Leu
Thr Ile Glu Tyr
Thr Ile Tyr Glu
Thr Lys Asn Tyr
Thr Lys Tyr Asn
Thr Leu Glu Tyr
Thr Leu Tyr Glu
Thr Asn Lys Tyr
Thr Asn Tyr Lys
Thr Tyr Glu Ile
Thr Tyr Glu Leu
Thr Tyr Ile Glu
Thr Tyr Lys Asn
Thr Tyr Leu Glu
Thr Tyr Asn Lys
Tyr Glu Ile Thr
Tyr Glu Leu Thr
Tyr Glu Thr Ile
Tyr Glu Thr Leu
Tyr Ile Glu Thr
Tyr Ile Thr Glu
Tyr Lys Asn Thr
Tyr Lys Gln Ser
Tyr Lys Ser Gln
Tyr Lys Thr Asn
Tyr Leu Glu Thr
Tyr Leu Thr Glu
Tyr Asn Lys Thr
Tyr Asn Thr Lys
Tyr Gln Lys Ser
Tyr Gln Ser Lys
Tyr Ser Lys Gln
Tyr Ser Gln Lys
Tyr Thr Glu Ile
Tyr Thr Glu Leu
Tyr Thr Ile Glu
Tyr Thr Lys Asn
Tyr Thr Leu Glu
Tyr Thr Asn Lys
8-(2,3-dihydro-1H-inden-5-yl)-N-methoxy-2-(4-(1-methylpiperidin-4-yl)phenylamino)-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine-6-carboxamide
2,5-bis(2-ethylhexyl)-3,6-di(thiophen-2-yl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione
6-(4-(2-(((2S)-3-(9H-Carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)pyridine-3-carboxamide
LY377604 is a human β3-adrenergic receptor agonist with an EC50 of 2.4 nM and also a β1- and β2-adrenergic receptor antagonist.
Fedratinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EJ - Janus-associated kinase (jak) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C125450 - JAK2 Inhibitor
Sucrose-2-(2-methyl)butyryl-4-(4-methyl)pentanoate
Sucrose-2-(2-methyl)butyryl-4-(3-methyl)pentanoate
Sucrose-2-(3-methyl)pentanoyl-4-(2-methyl)butyrate
4-fluoro-N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-5-(4-oxazolylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
(1R)-2-(cyclopropylmethyl)-N-(2,4-difluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide
(1-acetyloxy-3-phosphonooxypropan-2-yl) (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
(1s,2s,3r,4ar,5r,6s,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5-[(2s)-hexahydrofuro[2,3-b]furan-2-yl]-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-2-yl propanoate
(1r,4ar,5s,6r,7s,8r,8ar)-5-[(1s)-1-(acetyloxy)-2-(5-oxo-2h-furan-3-yl)ethyl]-6,8-dihydroxy-8a-(hydroxymethyl)-5,6-dimethyl-hexahydrospiro[naphthalene-1,2'-oxiran]-7-yl (2s)-2-methylbutanoate
(3s,4e,7s,8r,9e,12r)-12-[(2z)-but-2-en-2-yl]-8-{[(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,9-dimethyl-2,6-dioxo-1-oxacyclododeca-4,9-dien-7-yl 3-methylbutanoate
(3e,5s,8r,9r,10s,11r,13r,15r,16s,18z)-11-ethenyl-2,9,20,24,27-pentahydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,18,20,26-pentaene-7,28-dione
12-(but-2-en-2-yl)-8-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,9-dimethyl-2,6-dioxo-1-oxacyclododeca-4,9-dien-7-yl 3-methylbutanoate
14,15-dihydro-15β-methoxy-3-epicaryoptin
{"Ingredient_id": "HBIN001318","Ingredient_name": "14,15-dihydro-15\u03b2-methoxy-3-epicaryoptin","Alias": "NA","Ingredient_formula": "C27H40O10","Ingredient_Smile": "CC1CC(C2(C(C1(C)C3CC4CC(OC4O3)OC)CCC(C25CO5)OC(=O)C)COC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5669","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}